MOTS-c where to buy has one honest answer, and it is not a pharmacy. No regulator has approved this peptide, so the supplier is the only quality control in the chain.
Key takeaways
- MOTS-c is a 16-amino-acid peptide encoded inside mitochondrial DNA, described by Lee and colleagues in Cell Metabolism in 2015 as an AMPK-linked regulator of metabolic homeostasis. That description is why it gets called an exercise mimetic, and it holds no marketing authorization anywhere.
- There is no prescription to obtain and no pharmacy that can dispense it, so the buying decision is 100% a supplier-quality decision.
- On a peptide this short, identity carries more weight than purity. Mass spectrometry answers whether the powder is MOTS-c at all; a purity percentage only describes how much of something the vial holds.
- There is one SKU, 10 mg. No vial-size arithmetic is available to you here, so per-milligram thinking shifts to quantity and to whether the material is real.
- Ascension Peptides publishes two independent third-party certificates per batch and dispatches domestically. The 10 mg vial lists at $75.00 and falls to $37.50 with the code, which is $3.75/mg.
The vendor we point lifters to
MOTS-c from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
Buying 3, 5 or 10 vials takes 3%, 5% or 10% off the list price. Free shipping starts at $250, which one discounted vial does not reach.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 19, 2026.
Why the supplier is the whole decision
With an approved drug, the manufacturer is audited, the label is legally binding, and a pharmacist stands between the factory and you. MOTS-c has none of that. It carries no FDA, EMA or MHRA authorization, which means no prescription exists to be written and no compounding pharmacy can lawfully produce it for human use. Everything on the open market is sold as laboratory research material.
Strip out the regulator and the pharmacist and one actor is left holding every quality question: the supplier. So the standards below are not a nice-to-have layer on top of a purchase. They are the purchase.
What an exercise-mimetic claim actually claims
This site exists because lifters care about lean tissue, so it is worth being exact about why a mitochondrial peptide shows up here at all.
MOTS-c is encoded within the mitochondrial 12S rRNA region rather than in nuclear DNA, which already makes it unusual. The 2015 Cell Metabolism work by Lee and colleagues described it acting on the folate cycle in a way that ends in AMPK activation, with rodent data showing reduced diet-induced obesity and improved insulin sensitivity. AMPK is the same energy-sensing node that endurance training pushes on, and that overlap is the entire basis of the exercise-mimetic label.
Read that carefully, because the label is doing less work than it sounds like it is. A shared signaling node is not a shared outcome. Training produces mechanical tension, substrate depletion, mitochondrial biogenesis and a hormonal response, in a sequence your body has spent a lifetime adapting to. A peptide that touches one node in that network is not a substitute for the session. Nothing published shows MOTS-c improving performance or body composition in trained humans, because that study has not been run.
The nearest thing to a human program was CB4211, a MOTS-c analogue rather than MOTS-c itself, developed by CohBar and taken through a Phase 1a/1b study. CohBar later wound down. There is no Phase 3 and no large human efficacy trial for either molecule.
MOTS-c where to buy: the standards a supplier has to meet
Six standards do most of the filtering. They are ordered by how much they tell you, not by how easy they are to check.
| Standard | What a pass looks like | What it costs you when it fails |
|---|---|---|
| Batch-specific COA | A dated certificate tied to a lot number that matches the vial in the box | You hold a document about material you did not receive |
| Named testing lab | The facility is named and independently searchable | "Third-party tested" is a phrase, not a result |
| Mass spec identity | Molecular weight confirmation for a 16-residue sequence | You cannot tell MOTS-c from a cheaper peptide of similar appearance |
| HPLC purity | A chromatogram, not a percentage typed into a product description | The number is unsourced and unfalsifiable |
| Domestic dispatch | A stated warehouse and a cutoff time for same-day shipping | Weeks in transit, customs exposure, and heat on a lyophilized cake |
| Research-use labeling | Laboratory-use-only language, no dosing charts, no body-composition claims | A vendor that ignores one rule is telling you how it treats the others |
There is no seventh standard about vial size, and that is deliberate. MOTS-c is sold in a single 10 mg presentation, so the per-milligram optimization available on multi-strength peptides simply does not exist here. Anyone comparing MOTS-c vial sizes has imported a habit from another compound. The only remaining axis is quantity, which our MOTS-c price breakdown works through properly.
Scoring Ascension Peptides against the standards
Ascension publishes two independent third-party certificates per batch rather than one, currently Kovera Labs batch 24-05260628 and MZ Biolabs batch 24-01260229. Two labs on the same material is a harder claim to fake than one, because a reshipper buying anonymous powder cannot cheaply produce a second matching report.
On dispatch, orders placed before 2pm CST ship the same day from the US, which removes customs from the equation for domestic buyers and keeps the material out of a long unrefrigerated transit. On pricing transparency, the arithmetic is public and single-step: $75.00 list, $37.50 with PEPTIDEDECK, $3.75/mg. On labeling, the product page carries research-use-only language and no dosing guidance.
One honest caveat. This is an assessment of documentation, not a laboratory result. We have not assayed a vial, and nobody writing a buying guide has. What can be checked from outside is whether certificates exist, name real facilities, and tie to specific batches, and on that basis the standards clear.
The standard most buyers skip
Purity gets all the attention and identity gets almost none, which is backwards for a peptide this small.
MOTS-c is 16 amino acids, sequence MRWQEMGYIFYPRKLR. Short peptides are cheap to synthesize, which is good news for price and bad news for verification, because a truncated sequence, a substituted residue or an entirely different short peptide can all present as a white lyophilized cake with a high purity figure attached. A purity chromatogram tells you what proportion of the contents is one dominant species. Only a mass spectrometry result tells you that the species has the molecular weight MOTS-c should have.
If a certificate offers a purity percentage and no mass confirmation, the number describes an unidentified compound. Treat that as a fail, not as partial credit.
What none of this does for a bulk or a cut
A supplier that clears all six standards has sold you verified material. It has not sold you an adaptation.
Mitochondrial density, capillarization and the endurance qualities lifters chase in an off-season all respond to training volume and to time. Insulin sensitivity during a bulk responds to training, sleep, and how far above maintenance you are sitting. Those levers are covered here in resistance training and myostatin and in myostatin and insulin resistance, and no research peptide replaces either.
The reader most likely to arrive on this page is someone running or considering an incretin drug and worried about lean mass, which is a real concern with real trial evidence behind it, laid out in myostatin and GLP-1 muscle loss. MOTS-c does not address that mechanism, and the pharmacological candidates that might, bimagrumab among them, are still in trials and are not for sale. If you are working through supplier questions on the incretin side as well, the same standards logic is applied to that market in our retatrutide where to buy guide. The same six standards applied to a compound sold against stress and session focus are in Semax where to buy.
MOTS-c peptide where to buy from outside the US
The standards do not change; the shipping line does. There is no MHRA or EMA authorization for MOTS-c, so a UK or EU buyer has no domestic legal supply route either, and a US shipment inward is an import of unapproved material. Customs risk, VAT and handling fees all sit with the buyer, and UK-facing "stockists" are frequently reshippers adding a margin and no testing to the same US product. That is a straight statement of the position, not a workaround.
Frequently asked questions
Is MOTS-c approved anywhere, or is research-use labeling just a formality?
It is not a formality. MOTS-c holds no marketing authorization from the FDA, EMA or MHRA, and no approved medicine contains it. Research-use labeling is an accurate description of what is legally being sold, which is why a vendor that replaces it with dosing advice has stepped outside the rules it operates under.
Does a high purity figure mean the vial contains MOTS-c?
No. Purity describes what fraction of the contents is the dominant species. Identity, confirmed by mass spectrometry against the expected molecular weight of a 16-residue sequence, is what establishes that the species is MOTS-c. A purity number without an identity result is a statistic about an unknown powder.
Is there a larger vial that brings the price per milligram down?
No. MOTS-c is sold in a single 10 mg presentation, so the multi-strength comparison you can run on some other research peptides is not available. At $37.50 with the code the vial works out at $3.75/mg, and the only other lever is quantity, where 3, 5 or 10 vials take 3%, 5% or 10% off the list price.
Does the code combine with the quantity discounts?
We have seen nothing documented that says it does, so plan on the assumption that it does not and read the total on the checkout page before you confirm. Treating an undocumented stack as real is how people talk themselves into an order they did not intend to place.
Has any published work looked at MOTS-c in trained humans?
Not in the way a lifter would want. The core literature is cell and rodent work, and the only human clinical data belongs to CB4211, an analogue rather than MOTS-c itself, which completed a Phase 1a/1b study before its developer wound down. No Phase 3 program exists, and no trial has measured strength, hypertrophy or endurance outcomes in trained people.
This article is for educational purposes only and is not medical advice. MOTS-c is an unapproved compound with no marketing authorization in any market, and material sold by research suppliers is labeled for laboratory use only and not for human consumption. Speak with a qualified healthcare professional before making any decision involving peptides, injections, or off-label compounds.